Lipum Ab Stock EBITDA

LIPUM Stock  SEK 14.30  1.90  11.73%   
Lipum AB fundamentals help investors to digest information that contributes to Lipum AB's financial success or failures. It also enables traders to predict the movement of Lipum Stock. The fundamental analysis module provides a way to measure Lipum AB's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Lipum AB stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Lipum AB Company EBITDA Analysis

Lipum AB's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

 = 

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Lipum AB EBITDA

    
  (52.11 M)  
Most of Lipum AB's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Lipum AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition

According to the company disclosure, Lipum AB reported earnings before interest,tax, depreciation and amortization of (52.11 Million). This is 105.94% lower than that of the Healthcare sector and 152.02% lower than that of the Biotechnology industry. The ebitda for all Sweden stocks is 101.34% higher than that of the company.

Lipum EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Lipum AB's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Lipum AB could also be used in its relative valuation, which is a method of valuing Lipum AB by comparing valuation metrics of similar companies.
Lipum AB is currently under evaluation in ebitda category among its peers.

Lipum Fundamentals

About Lipum AB Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Lipum AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lipum AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lipum AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Lipum Stock Analysis

When running Lipum AB's price analysis, check to measure Lipum AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lipum AB is operating at the current time. Most of Lipum AB's value examination focuses on studying past and present price action to predict the probability of Lipum AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lipum AB's price. Additionally, you may evaluate how the addition of Lipum AB to your portfolios can decrease your overall portfolio volatility.